Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations

Documenti analoghi

• Commentary/Response to Damkier et al.
  di: Liana Martirosyan, et al.
  Pubblicazione: (2024)
• Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe
  di: Rosa Gini, et al.
  Pubblicazione: (2024)
• Effectiveness of the Additional Risk Minimisation Measures for Valproate Among Healthcare Professionals and Patients: A Cross‐Sectional Survey in Six European Countries
  di: Sandrine Colas, et al.
  Pubblicazione: (2024)
• Post‐Market Evidence for Cancer Medicines in Regulatory and Clinical Decision‐Making: A Scoping Review
  di: Eliza J. McEwin, et al.
  Pubblicazione: (2025)
• Impact of Regulatory Interventions on Ulipristal Acetate 5 mg (Esmya) Use in Spain: An Interrupted Time‐Series Analysis
  di: Marta Monreal‐Di Bello, et al.
  Pubblicazione: (2024)